K. Mallett

Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients.

B. O'connor, C. Corrigan, T. Loke, 2006, The Journal of allergy and clinical immunology.

Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis.

G. Scadding, C. Corrigan, Tak H. Lee, 2005, The Journal of allergy and clinical immunology.

Expression of prostaglandin E(2) receptor subtypes on cells in sputum from patients with asthma and controls: effect of allergen inhalational challenge.

B. O'connor, C. Corrigan, Tak H. Lee, 2004, The Journal of allergy and clinical immunology.

Thymic Stromal Lymphopoietin Expression Is Increased in Asthmatic Airways and Correlates with Expression of Th2-Attracting Chemokines and Disease Severity1

D. Robinson, B. O'connor, C. Corrigan, 2005, The Journal of Immunology.

Phase I and pharmacodynamic trial of AT9283, an aurora kinase inhibitor, in patients with refractory leukemia

H. Kantarjian, F. Ravandi, G. Borthakur, 2008 .

A dose-escalation and pharmacodynamic study of AT9283 in patients with refractory solid tumours

I. Judson, M. Squires, H. Arkenau, 2008 .